Market Overview:
The global pizotifen market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The hospital segment is expected to dominate the market in terms of revenue share, followed by the drug store segment, during the forecast period. The antimigraine agent application segment is estimated to account for a major share of the global pizotifen market in 2018 and is projected to maintain its dominance throughout the forecast period. North America accounted for a major share of the global pizotifen market in 2017 and is projected to maintain its dominance throughout the forecast period.
Product Definition:
Pizotifen is a drug prescribed for the prevention of migraine headaches. It is in a class of drugs called serotonin receptor antagonists.
Hospital:
Hospital is a drug that helps to reduce the inflammation of the lungs in people who have been injured in an accident or who are suffering from asthma. It works by reducing the amount of histamine produced by cells in response to allergic reactions.
The global Pizotifen market is expected to grow at a significant rate over the forecast period owing to increasing prevalence of chronic diseases such as allergies, asthma,.
Drug Store:
A drug store is a facility where pharmaceutical products are purchased and stored for future use. Drug stores can be retail or wholesale, government-operated or privately owned. They can also be located on the internet as well as in pharmacies.
The global market for drugs is expected to grow at a lucrative rate over the forecast period owing to factors such as aging population, increasing prevalence of chronic diseases, rising healthcare expenditure and technological advancements in terms of new formulations and delivery systems.
Application Insights:
The global pizotifen market is segmented by application into antimigraine agent, serotonin receptor antagonist and others. The other applications include treating depression, urinary incontinence and premenstrual syndrome (PMS). The antimigraine agent segment dominated the overall industry in terms of revenue in 2017 owing to high usage rates for migraine treatment across various regions.
The European Medicines Agency has approved the Migraine Therapy (pizotifen) as a monotherapy product for adults with migraine who have had no success with other treatments or have suffered from intolerability associated with CGRP-analogues. This approval was based on positive results from clinical trials that compared pizotifen to placebo regarding pain relief during migraines.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities, rising healthcare expenditure, and high prevalence of Migraineurs in U.S & Canada that are driving demand for pizotifen tablets and other drugs used for treatment of this condition.
In China, Sun Pharmaceutical Industries Ltd., developed a generic version called Fycompa (tarenflurbil) after receiving approval from China Food and Drug Administration (CFDA).
Growth Factors:
- Increasing prevalence of migraine and other headache disorders
- Growing awareness about the benefits of Pizotifen for the treatment of migraine and other headache disorders
- Rising demand for effective and safe medications for the treatment of migraine and other headache disorders
- Availability of generic versions of Pizotifen in major markets worldwide
- Launch of new products by key players in the Pizotifen market
Scope Of The Report
Report Attributes
Report Details
Report Title
Pizotifen Market Research Report
By Type
Hospital, Drug Store
By Application
Antimigraine Agent, Serotonin Receptor Antagonist
By Companies
Ibn Sina Pharmaceutical, Duopharma Biotech, Aristopharma, Novartis, AFT Pharmaceuticals, Teva Pharmaceuticals, Sine Pharmaceutical, Laema Chemi Pharma, Kalbe
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
189
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Pizotifen Market Report Segments:
The global Pizotifen market is segmented on the basis of:
Types
Hospital, Drug Store
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antimigraine Agent, Serotonin Receptor Antagonist
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ibn Sina Pharmaceutical
- Duopharma Biotech
- Aristopharma
- Novartis
- AFT Pharmaceuticals
- Teva Pharmaceuticals
- Sine Pharmaceutical
- Laema Chemi Pharma
- Kalbe
Highlights of The Pizotifen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospital
- Drug Store
- By Application:
- Antimigraine Agent
- Serotonin Receptor Antagonist
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pizotifen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pizotifen is a medication used to treat asthma. It works by reducing the amount of air that is breathed in, which helps to improve breathing. Pizotifen can also reduce the number of episodes of wheezing and chest tightness.
Some of the key players operating in the pizotifen market are Ibn Sina Pharmaceutical, Duopharma Biotech, Aristopharma, Novartis, AFT Pharmaceuticals, Teva Pharmaceuticals, Sine Pharmaceutical, Laema Chemi Pharma, Kalbe.
The pizotifen market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pizotifen Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pizotifen Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pizotifen Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pizotifen Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pizotifen Market Size & Forecast, 2018-2028
4.5.1 Pizotifen Market Size and Y-o-Y Growth
4.5.2 Pizotifen Market Absolute $ Opportunity
Chapter 5 Global Pizotifen Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pizotifen Market Size Forecast by Type
5.2.1 Hospital
5.2.2 Drug Store
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pizotifen Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pizotifen Market Size Forecast by Applications
6.2.1 Antimigraine Agent
6.2.2 Serotonin Receptor Antagonist
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pizotifen Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pizotifen Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pizotifen Analysis and Forecast
9.1 Introduction
9.2 North America Pizotifen Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pizotifen Market Size Forecast by Type
9.6.1 Hospital
9.6.2 Drug Store
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pizotifen Market Size Forecast by Applications
9.10.1 Antimigraine Agent
9.10.2 Serotonin Receptor Antagonist
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pizotifen Analysis and Forecast
10.1 Introduction
10.2 Europe Pizotifen Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pizotifen Market Size Forecast by Type
10.6.1 Hospital
10.6.2 Drug Store
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pizotifen Market Size Forecast by Applications
10.10.1 Antimigraine Agent
10.10.2 Serotonin Receptor Antagonist
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pizotifen Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pizotifen Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pizotifen Market Size Forecast by Type
11.6.1 Hospital
11.6.2 Drug Store
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pizotifen Market Size Forecast by Applications
11.10.1 Antimigraine Agent
11.10.2 Serotonin Receptor Antagonist
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pizotifen Analysis and Forecast
12.1 Introduction
12.2 Latin America Pizotifen Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pizotifen Market Size Forecast by Type
12.6.1 Hospital
12.6.2 Drug Store
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pizotifen Market Size Forecast by Applications
12.10.1 Antimigraine Agent
12.10.2 Serotonin Receptor Antagonist
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pizotifen Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pizotifen Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pizotifen Market Size Forecast by Type
13.6.1 Hospital
13.6.2 Drug Store
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pizotifen Market Size Forecast by Applications
13.10.1 Antimigraine Agent
13.10.2 Serotonin Receptor Antagonist
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pizotifen Market: Competitive Dashboard
14.2 Global Pizotifen Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ibn Sina Pharmaceutical
14.3.2 Duopharma Biotech
14.3.3 Aristopharma
14.3.4 Novartis
14.3.5 AFT Pharmaceuticals
14.3.6 Teva Pharmaceuticals
14.3.7 Sine Pharmaceutical
14.3.8 Laema Chemi Pharma
14.3.9 Kalbe
